Is a complete HSCS research report available?

No complete published report is available for HeartSciences Inc. (HSCS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HeartSciences Inc. (HSCS)

NASDAQ: HSCS · USD

$2.95

-0.04 (-1.3%)· Recorded snapshot

Market cap	14.2M
Revenue (ttm)	4.5K
Net income (ttm)	-10.3M
EPS (ttm)	-$3.19
Shares out	4.8M
Volume	60,630.816
Beta	1.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.5K
Net income (ttm): -10.3M
EPS (ttm): -$3.19
Market cap: 14.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001468492
Company name	HeartSciences Inc.
Country	United States
Country code	US
CUSIP number	42254E302
Earnings date	2026-12-14
Earnings time	amc
Employees	14
Employees change	-1
Employees growth	-6.67%
Enterprise value	$18.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-09
Fiscal year end	April
Founded	2007
Industry	Medical Devices
IPO date	2022-06-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US42254E3027
Last 10-K release date	2026-07-23
Last earnings date	2026-09-14
Last refreshed	2026-11-04
Last stock split date	2024-05-17
Last stock split type	Reverse
Market cap	$14.2M
Market cap category	Nano-Cap
Next earnings date	2026-12-14
Options	No
Price	$2.95
Price currency	USD
Sector	Healthcare
SIC code	6199
Stock price date	2026-11-03
Symbol	HSCS
U.S. state	Texas
Website	https://heartsciences.com

Metric

Value

Amount currency

USD

CIK code

0001468492

Company name

HeartSciences Inc.

Country

United States

Country code

CUSIP number

42254E302

Earnings date

2026-12-14

Earnings time

amc

Employees

Employees change

-1

Employees growth

-6.67%

Enterprise value

$18.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-07-31

First seen

2026-05-09

Fiscal year end

April

Founded

2007

Industry

Medical Devices

IPO date

2022-06-15

Is primary listing

Yes

Is SPAC

ISIN number

US42254E3027

Last 10-K release date

2026-07-23

Last earnings date

2026-09-14

Last refreshed

2026-11-04

Last stock split date

2024-05-17

Last stock split type

Reverse

Market cap

$14.2M

Market cap category

Nano-Cap

Next earnings date

2026-12-14

Options

Price

$2.95

Price currency

USD

Sector

Healthcare

SIC code

6199

Stock price date

2026-11-03

Symbol

HSCS

U.S. state

Texas

Website

https://heartsciences.com

Metric	Value
Earnings yield	-108.11%
EV/Sales	4,013.08x
FCF / EV yield	-37.47%
FCF yield	-47.99%
Forward EV/Sales	279x
Forward P/S	217.85x
Industry forward P/E	20.34x
Industry P/E	39.98x
P/S ratio	3,133.55x
Sector forward P/E	24x
Sector P/E	49.18x

Metric

Value

Earnings yield

-108.11%

EV/Sales

4,013.08x

FCF / EV yield

-37.47%

FCF yield

-47.99%

Forward EV/Sales

279x

Forward P/S

217.85x

Industry forward P/E

20.34x

Industry P/E

39.98x

P/S ratio

3,133.55x

Sector forward P/E

24x

Sector P/E

49.18x

Metric	Value
Gross margin	60.88%
Operating margin	-209,733.08%
Pretax margin	-227,024.23%
Profit per employee	$-732,802
Revenue per employee	$323
ROA	-116.44%
ROA (5Y)	-107.45%
ROCE	499.92%
ROE	-1,851.9%
ROIC	-167.82%
SBC / revenue	41,529.41%

Metric

Value

Gross margin

60.88%

Operating margin

-209,733.08%

Pretax margin

-227,024.23%

Profit per employee

$-732,802

Revenue per employee

$323

ROA

-116.44%

ROA (5Y)

-107.45%

ROCE

499.92%

ROE

-1,851.9%

ROIC

-167.82%

SBC / revenue

41,529.41%

Metric	Value
EPS growth quarters	5
EPS growth years	4
Gross profit growth	-23.8%
Gross profit growth (Q)	17.54%
Gross profit growth 3Y	32.23%
Gross profit growth 5Y	-31.1%
Net income growth years	0
Revenue growth	-27.7%
Revenue growth (Q)	10.53%
Revenue growth 3Y	32.33%
Revenue growth 5Y	-41.18%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-23.8%

Gross profit growth (Q)

17.54%

Gross profit growth 3Y

32.23%

Gross profit growth 5Y

-31.1%

Net income growth years

Revenue growth

-27.7%

Revenue growth (Q)

10.53%

Revenue growth 3Y

32.33%

Revenue growth 5Y

-41.18%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3,554
Depreciation and amortization	$27,012
EBIT	$-9.5M
EBITDA	$-9.5M
EPS	$-3.19
FCF per share	$-1.42
Financing cash flow	$4.4M
Free cash flow	$-6.8M
Free cash flow minus SBC	$-8.7M
Gross profit	$2,751
Investing cash flow	$-323,745
Net borrowing	$2.4M
Net cash flow	$-2.8M
Net income	$-10.3M
Operating cash flow minus SBC	$-8.7M
Operating income	$-9.5M
Revenue	$4,519
Stock-based compensation	$1.9M

Metric

Value

Capital expenditures

$-3,554

Depreciation and amortization

$27,012

EBIT

$-9.5M

EBITDA

$-9.5M

EPS

$-3.19

FCF per share

$-1.42

Financing cash flow

$4.4M

Free cash flow

$-6.8M

Free cash flow minus SBC

$-8.7M

Gross profit

$2,751

Investing cash flow

$-323,745

Net borrowing

$2.4M

Net cash flow

$-2.8M

Net income

$-10.3M

Operating cash flow minus SBC

$-8.7M

Operating income

$-9.5M

Revenue

$4,519

Stock-based compensation

$1.9M

Metric	Value
Altman Z-Score	-42.17
Book value per share	$-0.52
Interest coverage	-11.78
Long-term assets	$2.9M
Long-term liabilities	$137,266
Net cash (debt)	$-4M
Net cash / market cap	-28.07%
Piotroski F-Score	2
Property, plant and equipment	$272,851
Shareholders' equity	$-2M
Tangible book value	$-4.7M
Tangible book value per share	$-1.20
Total assets	$3.7M
Total cash	$29,906
Total debt	$4M
Total liabilities	$5.8M
WACC	14.42%

Metric

Value

Altman Z-Score

-42.17

Book value per share

$-0.52

Interest coverage

-11.78

Long-term assets

$2.9M

Long-term liabilities

$137,266

Net cash (debt)

$-4M

Net cash / market cap

-28.07%

Piotroski F-Score

Property, plant and equipment

$272,851

Shareholders' equity

$-2M

Tangible book value

$-4.7M

Tangible book value per share

$-1.20

Total assets

$3.7M

Total cash

$29,906

Total debt

$4M

Total liabilities

$5.8M

WACC

14.42%

Metric	Value
Asset turnover	0
Current assets	$811,768
Current liabilities	$5.6M
Current ratio	0.14
Inventory turnover	0
Net working capital	$-983,852
Quick ratio	0.01
Working capital	$-4.8M
Working capital turnover	-0

Metric

Value

Asset turnover

Current assets

$811,768

Current liabilities

$5.6M

Current ratio

0.14

Inventory turnover

Net working capital

$-983,852

Quick ratio

0.01

Working capital

$-4.8M

Working capital turnover

-0

Metric	Value
Buyback yield / dilution	-200.72%
Dividend yield	0%
Shareholder yield	-200.72%

Metric

Value

Buyback yield / dilution

-200.72%

Dividend yield

Shareholder yield

-200.72%

Metric	Value
150-day SMA	$2.67
1D price change	-1.34%
1M price change	-31.4%
1M total return	-31.4%
1W price change	-10.06%
1W total return	-10.06%
1Y price change	-3.28%
1Y return CAGR	-3.28%
1Y total return	-3.28%
20-day SMA	$3.20
200-day SMA	$2.71
3M price change	35.32%
3M total return	35.32%
3Y price change	-86.03%
3Y return CAGR	-48.1%
3Y total return	-86.03%
50-day SMA	$3.61
50-day SMA vs 200-day SMA	50over200
52-week high	$5.25
52-week high date	2026-09-21
52-week low	$1.63
52-week low date	2026-05-29
6M price change	48.24%
6M total return	48.24%
After-hours change	2.34%
After-hours close	$2.95
After-hours price	$3.02
All-time high	$600.00
All-time high date	2022-08-03
All-time low	$1.63
All-time low date	2026-05-29
Average true range (ATR)	$0.36
Average volume	90K
Beta (1Y)	-0.92
Beta (2Y)	0.47
Beta (5Y)	1.78
Change from 52-week high	-43.81%
Change from 52-week low	80.98%
Change from all-time high	-99.51%
Change from all-time low	80.98%
Change from open	-6.56%
Day's gap	5.59%
Dollar volume	$178,861
High price	$3.16
Low price	$2.88
Monthly RSI	37.13
Open price	$3.16
Position in 52-week range	25.27%
Premarket change	3.85%
Premarket close	$2.95
Premarket price	$3.06
Previous close	$2.99
Price vs 150-day SMA	10.69%
Price vs 20-day SMA	-7.93%
Price vs 200-day SMA	8.7%
Price vs 50-day SMA	-18.35%
Relative volume	0.67
Return from IPO open	-99.21%
Return from IPO price	-30.59%
RSI	41.9
Sharpe ratio	0.43
Sharpe ratio (3Y)	-0.09
Sortino ratio	0.85
Sortino ratio (3Y)	-0.09
Volume	60.6K
Weekly RSI	48.9
YTD price change	-4.53%
YTD total return	-4.53%

Metric

Value

150-day SMA

$2.67

1D price change

-1.34%

1M price change

-31.4%

1M total return

-31.4%

1W price change

-10.06%

1W total return

-10.06%

1Y price change

-3.28%

1Y return CAGR

-3.28%

1Y total return

-3.28%

20-day SMA

$3.20

200-day SMA

$2.71

3M price change

35.32%

3M total return

35.32%

3Y price change

-86.03%

3Y return CAGR

-48.1%

3Y total return

-86.03%

50-day SMA

$3.61

50-day SMA vs 200-day SMA

50over200

52-week high

$5.25

52-week high date

2026-09-21

52-week low

$1.63

52-week low date

2026-05-29

6M price change

48.24%

6M total return

48.24%

After-hours change

2.34%

After-hours close

$2.95

After-hours price

$3.02

All-time high

$600.00

All-time high date

2022-08-03

All-time low

$1.63

All-time low date

2026-05-29

Average true range (ATR)

$0.36

Average volume

90K

Beta (1Y)

-0.92

Beta (2Y)

0.47

Beta (5Y)

1.78

Change from 52-week high

-43.81%

Change from 52-week low

80.98%

Change from all-time high

-99.51%

Change from all-time low

80.98%

Change from open

-6.56%

Day's gap

5.59%

Dollar volume

$178,861

High price

$3.16

Low price

$2.88

Monthly RSI

37.13

Open price

$3.16

Position in 52-week range

25.27%

Premarket change

3.85%

Premarket close

$2.95

Premarket price

$3.06

Previous close

$2.99

Price vs 150-day SMA

10.69%

Price vs 20-day SMA

-7.93%

Price vs 200-day SMA

8.7%

Price vs 50-day SMA

-18.35%

Relative volume

0.67

Return from IPO open

-99.21%

Return from IPO price

-30.59%

RSI

41.9

Sharpe ratio

0.43

Sharpe ratio (3Y)

-0.09

Sortino ratio

0.85

Sortino ratio (3Y)

-0.09

Volume

60.6K

Weekly RSI

48.9

YTD price change

-4.53%

YTD total return

-4.53%

Metric	Value
Float	3.4M
Float percentage	70.7%
Shares change (QoQ)	16.78%
Shares change (YoY)	200.72%
Shares held by insiders	18.17%
Shares held by institutions	6.88%
Shares outstanding	4.8M
Short % of float	1.86%
Short % of shares	1.32%
Short ratio	0.3 days

Metric

Value

Float

3.4M

Float percentage

70.7%

Shares change (QoQ)

16.78%

Shares change (YoY)

200.72%

Shares held by insiders

18.17%

Shares held by institutions

6.88%

Shares outstanding

4.8M

Short % of float

1.86%

Short % of shares

1.32%

Short ratio

0.3 days

HeartSciences Inc. (HSCS)

Price

Financial snapshot

Fair-value bridge

Latest news · HSCS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HSCS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HSCS

Frequently asked questions